최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Advanced therapeutics, v.6 no.2, 2023년, pp.2200161 -
Lee, Sang‐Yun (Department of Biomedical Engineering Gachon University Seongnam 13120 Republic of Korea) , Hwang, Hyun Ju (Central R & D Center, Medical & Bio Decision (MBD) Co., Ltd Suwon 16229 Republic of Korea) , Lee, Dong Woo (Department of Biomedical Engineering Gachon University Seongnam 13120 Republic of Korea)
AbstractA 3D‐cell spotter is developed to maximize the efficiency of 3D cell‐based high‐throughput screening (3D‐HTS). The performance of 3D‐HTS is verified through heatmap analysis for distinguishing responses to targeted drugs according to the expression of HER2 ...
Pampaloni, Francesco, Reynaud, Emmanuel G., Stelzer, Ernst H. K.. The third dimension bridges the gap between cell culture and live tissue. Nature reviews. Molecular cell biology, vol.8, no.10, 839-845.
Ravi, Maddaly, Paramesh, V., Kaviya, S.R., Anuradha, E., Solomon, F.D. Paul. 3D Cell Culture Systems: Advantages and Applications. Journal of cellular physiology, vol.230, no.1, 16-26.
Booij, Tijmen H., Price, Leo S., Danen, Erik H.J.. 3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis. SLAS discovery : advancing life sciences R & D, vol.24, no.6, 615-627.
Candini, Olivia, Grisendi, Giulia, Foppiani, Elisabetta Manuela, Brogli, Matteo, Aramini, Beatrice, Masciale, Valentina, Spano, Carlotta, Petrachi, Tiziana, Veronesi, Elena, Conte, Pierfranco, Mari, Giorgio, Dominici, Massimo. A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. Scientific reports, vol.9, 7154-.
Langhans, Sigrid A.. Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning. Frontiers in pharmacology, vol.9, 6-.
Chramiec, Alan, Teles, Diogo, Yeager, Keith, Marturano-Kruik, Alessandro, Pak, Joseph, Chen, Timothy, Hao, Luke, Wang, Miranda, Lock, Roberta, Tavakol, Daniel Naveed, Lee, Marcus Busub, Kim, Jinho, Ronaldson-Bouchard, Kacey, Vunjak-Novakovic, Gordana. Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety. Lab on a chip, vol.20, no.23, 4357-4372.
Wang, Yichun, Jeon, Hyunsu. 3D cell cultures toward quantitative high-throughput drug screening. Trends in pharmacological sciences, vol.43, no.7, 569-581.
Press, Michael F, Lenz, Heinz-Josef. EGFR, HER2 and VEGF Pathways : Validated Targets for Cancer Treatment. Drugs, vol.67, no.14, 2045-2075.
Cohen, Bruce D., Kiener, Peter A., Green, Janell M., Foy, Linda, Fell, H. Perry, Zhang, Ke. The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells. The Journal of biological chemistry, vol.271, no.48, 30897-30903.
Schlessinger, Joseph. Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor. Cell, vol.110, no.6, 669-672.
Yu, Jinfeng, Fang, Tong, Yun, Chengyu, Liu, Xue, Cai, Xiaoqing. Antibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor Family in Cancers. Frontiers in molecular biosciences, vol.9, 847835-.
Sheng, Q, Liu, J. The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer. The British journal of cancer, vol.104, no.8, 1241-1245.
Chen, Jun, Kinoshita, Taisei, Sukbuntherng, Juthamas, Chang, Betty Y., Elias, Laurence. Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth. Molecular cancer therapeutics, vol.15, no.12, 2835-2844.
J. Natl. Cancer Inst. Gao W. 106 2014
Wang, Lingzhi, Syn, Nicholas Li-Xun, Subhash, Vinod Vijay, Any, Yijia, Thuya, Win Lwin, Cheow, Esther Sok Hwee, Kong, Liren, Yu, Fenggang, Peethala, Praveen C., Wong, Andrea Li-Ann, Laljibhai, Hirpara J., Chinnathambi, Arunachalam, Ong, Pei Shi, Ho, Paul Chi-Lui, Sethi, Gautam, Yong, Wei Peng, Goh, Boon Cher. Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling. Cancer letters, vol.417, 152-160.
LaBonte, Melissa J., Wilson, Peter M., Fazzone, Will, Russell, Jared, Louie, Stan G., El-Khoueiry, Anthony, Lenz, Heinz-Josef, Ladner, Robert D.. The Dual EGFR/HER2 Inhibitor Lapatinib Synergistically Enhances the Antitumor Activity of the Histone Deacetylase Inhibitor Panobinostat in Colorectal Cancer Models. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.71, no.10, 3635-3648.
Lee, K.Y., Mooney, D.J.. Alginate: Properties and biomedical applications. Progress in polymer science, vol.37, no.1, 106-126.
Lee, Sang-Yun, Doh, Il, Nam, Do-Hyun, Lee, Dong Woo. 3D Cell-Based High-Content Screening (HCS) Using a Micropillar and Microwell Chip Platform. Analytical chemistry, vol.90, no.14, 8354-8361.
Lee, Sang-Yun, Teng, Yvonne, Son, Miseol, Ku, Bosung, Hwang, Hyun Ju, Tergaonkar, Vinay, Chow, Pierce Kah-Hoe, Lee, Dong Woo, Nam, Do-Hyun. Three-Dimensional Aggregated Spheroid Model of Hepatocellular Carcinoma Using a 96-Pillar/Well Plate. Molecules a journal of synthetic chemistry and natural product chemistry, vol.26, no.16, 4949-.
Bonnans, Caroline, Chou, Jonathan, Werb, Zena. Remodelling the extracellular matrix in development and disease. Nature reviews. Molecular cell biology, vol.15, no.12, 786-801.
Oncol. Lett. Lv D. 6999 14 2017
Melissaridou, Styliani, Wiechec, Emilia, Magan, Mustafa, Jain, Mayur Vilas, Chung, Man Ki, Farnebo, Lovisa, Roberg, Karin. The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer. Cancer cell international, vol.19, 16-.
Salinas-Vera, Yarely M., Valdés, Jesús, Pérez-Navarro, Yussel, Mandujano-Lazaro, Gilberto, Marchat, Laurence A., Ramos-Payán, Rosalio, Nuñez-Olvera, Stephanie I., Pérez-Plascencia, Carlos, López-Camarillo, César. Three-Dimensional 3D Culture Models in Gynecological and Breast Cancer Research. Frontiers in oncology, vol.12, 826113-.
OncoTargets Ther. Nelson V. 135 6 2013
Diaz, Nills, Minton, Susan, Cox, Charles, Bowman, Tammy, Gritsko, Tanya, Garcia, Roy, Eweis, Ibrahim, Wloch, Marek, Livingston, Sandy, Seijo, Ed, Cantor, Alan, Lee, Ji-Hyun, Beam, Craig A., Sullivan, Daniel, Jove, Richard, Muro-Cacho, Carlos A.. Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.12, no.1, 20-28.
Soria, J.-C., Cortes, J., Massard, C., Armand, J.-P., De Andreis, D., Ropert, S., Lopez, E., Catteau, A., James, J., Marier, J.-F., Beliveau, M., Martell, R.E., Baselga, J.. Corrections to “Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors”. Annals of oncology : official journal of the European Society for Medical Oncology, vol.30, no.6, 1020-.
Atalay, G., Cardoso, F., Awada, A., Piccart, M. J.. Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, vol.14, no.9, 1346-1363.
Zeng, Fanpu, Wang, Fang, Zheng, Zongheng, Chen, Zhen, Wah To, Kenneth Kin, Zhang, Hong, Han, Qian, Fu, Liwu. Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo. Acta pharmaceutica Sinica. B, vol.10, no.5, 799-811.
J. Thorac. Dis. Carpenter R. L. 6 4 2012
Ann. Intern. Med. Maitland M. L. 145 2006
Amelia, Tasia, Kartasasmita, Rahmana Emran, Ohwada, Tomohiko, Tjahjono, Daryono Hadi. Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors. Molecules : a journal of synthetic chemistry and natural product chemistry, vol.27, no.3, 819-.
PLoS One Kim H. P. 6 4 2009
Breast Cancer Feldinger K. 7 9 2015
J. Chem. Theory Comput. Park J. 4 12 2016
Cancer Chemother. Pharmacol. Reardon D. A. 6 69 2012
Goudar, Ranjit K., Shi, Qing, Hjelmeland, Mark D., Keir, Stephen T., McLendon, Roger E., Wikstrand, Carol J., Reese, Elizabeth D., Conrad, Charles A., Traxler, Peter, Lane, Heidi A., Reardon, David A., Cavenee, Webster K., Wang, Xiao-Fan, Bigner, Darell D., Friedman, Henry S., Rich, Jeremy N.. Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition. Molecular cancer therapeutics, vol.4, no.1, 101-112.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.